Knollwood Investment Advisory’s West Pharmaceutical WST Stock Holding History

Knollwood Investment Advisory’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$211K	Hold	840	–	–	0.02%	295
2025 Q4	$231K	Hold	840	–	–	0.02%	306
2025 Q3	$220K	Buy	+840	New	+$204K	0.02%	339
2025 Q1	–	Sell	-6,700	Closed	-$2.19M	–	361
2024 Q4	$2.19M	Hold	6,700	–	–	0.23%	111
2024 Q3	$2.01M	Hold	6,700	–	–	0.22%	116
2024 Q2	$2.21M	Buy	6,700 +5,860	+698%	+$2.07M	0.25%	100
2024 Q1	$332K	Hold	840	–	–	0.06%	174
2023 Q4	$296K	Buy	+840	New	+$297K	0.06%	175

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Knollwood Investment Advisory's WST Position: Q1 2026 in Review

Knollwood Investment Advisory held its West Pharmaceutical (WST) position steady in Q1 2026 at 840 shares worth $211K. The position accounts for 0.02% of the portfolio, ranked #295.

Knollwood Investment Advisory first reported a position in WST in Q4 2023 and has held it in 8 quarters since. The position peaked at $2.21M in Q2 2024. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

Knollwood Investment Advisory held 840 shares of West Pharmaceutical worth $211K as of Q1 2026.
Knollwood Investment Advisory left its West Pharmaceutical share count unchanged in Q1 2026.
West Pharmaceutical made up 0.02% of Knollwood Investment Advisory's portfolio in Q1 2026, its #295 holding.
Knollwood Investment Advisory first reported a position in West Pharmaceutical in Q4 2023 and has held it in 8 quarters since.
Knollwood Investment Advisory's West Pharmaceutical position peaked at $2.21M in Q2 2024.
754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Knollwood Investment Advisory's 13F filing for Q1 2026, filed 14 May 2026.